Mercer Global Advisors Inc Akouos, Inc. Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.46 - $5.2 $248 - $525	-101 Reduced 0.12%	82,685 $388,000
Q1 2022 May 10, 2022	BUY	$4.16 - $9.08 $195 - $426	47 Added 0.06%	82,786 $393,000
Q4 2021 Feb 04, 2022	BUY	$7.65 - $11.38 $89,046 - $132,463	11,640 Added 16.37%	82,739 $703,000
Q3 2021 Nov 10, 2021	SELL	$9.93 - $13.59 $109 - $149	-11 Reduced 0.02%	71,099 $825,000
Q2 2021 Aug 10, 2021	SELL	$11.87 - $15.96 $1,187 - $1,596	-100 Reduced 0.14%	71,110 $892,000
Q1 2021 May 11, 2021	BUY	$13.87 - $21.04 $987,682 - $1.5 Million	71,210 New	71,210 $988,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.